![Frontiers | PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study Frontiers | PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study](https://www.frontiersin.org/files/Articles/693684/fonc-11-693684-HTML/image_m/fonc-11-693684-g001.jpg)
Frontiers | PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study
![A calculator based on prostate imaging reporting and data system version 2 (PI-RADS V2) is a promising prostate cancer predictor | Scientific Reports A calculator based on prostate imaging reporting and data system version 2 (PI-RADS V2) is a promising prostate cancer predictor | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-43427-9/MediaObjects/41598_2019_43427_Fig1_HTML.png)
A calculator based on prostate imaging reporting and data system version 2 (PI-RADS V2) is a promising prostate cancer predictor | Scientific Reports
![performance of PSA density with respect to multiple cutoff levels. Note... | Download Scientific Diagram performance of PSA density with respect to multiple cutoff levels. Note... | Download Scientific Diagram](https://www.researchgate.net/publication/10978140/figure/tbl2/AS:601775400820743@1520485844541/performance-of-PSA-density-with-respect-to-multiple-cutoff-levels-Note-the-unacceptable.png)
performance of PSA density with respect to multiple cutoff levels. Note... | Download Scientific Diagram
![Cancers | Free Full-Text | Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI Cancers | Free Full-Text | Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI](https://www.mdpi.com/cancers/cancers-14-02702/article_deploy/html/images/cancers-14-02702-g001-550.jpg)
Cancers | Free Full-Text | Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI
![Cancers | Free Full-Text | Comparative Analysis of PSA Density and an MRI-Based Predictive Model to Improve the Selection of Candidates for Prostate Biopsy Cancers | Free Full-Text | Comparative Analysis of PSA Density and an MRI-Based Predictive Model to Improve the Selection of Candidates for Prostate Biopsy](https://www.mdpi.com/cancers/cancers-14-02374/article_deploy/html/images/cancers-14-02374-g001a.png)
Cancers | Free Full-Text | Comparative Analysis of PSA Density and an MRI-Based Predictive Model to Improve the Selection of Candidates for Prostate Biopsy
![Combination of prostate imaging reporting and data system (PI‐RADS) score and prostate‐specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients - Washino - 2017 - BJU International - Wiley Online Library Combination of prostate imaging reporting and data system (PI‐RADS) score and prostate‐specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients - Washino - 2017 - BJU International - Wiley Online Library](https://bjui-journals.onlinelibrary.wiley.com/cms/asset/5da9764a-62c5-4aa4-8504-19064bd0cceb/bju13465-fig-0002-m.jpg)
Combination of prostate imaging reporting and data system (PI‐RADS) score and prostate‐specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients - Washino - 2017 - BJU International - Wiley Online Library
![Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer | Prostate Cancer and Prostatic Diseases Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41391-017-0024-7/MediaObjects/41391_2017_24_Fig1_HTML.jpg)
Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer | Prostate Cancer and Prostatic Diseases
![Prostate-specific Antigen Density Cutoff of 0.15 ng/ml/cc to Propose Prostate Biopsies to Patients with Negative Magnetic Resonance Imaging: Efficient Threshold or Legacy of the Past? - European Urology Focus Prostate-specific Antigen Density Cutoff of 0.15 ng/ml/cc to Propose Prostate Biopsies to Patients with Negative Magnetic Resonance Imaging: Efficient Threshold or Legacy of the Past? - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/attachment/a46107e3-2124-46ce-a2e7-7c48cf9f8ca2/gr1_lrg.jpg)
Prostate-specific Antigen Density Cutoff of 0.15 ng/ml/cc to Propose Prostate Biopsies to Patients with Negative Magnetic Resonance Imaging: Efficient Threshold or Legacy of the Past? - European Urology Focus
![When should therapeutic intervention take place for men on active surveillance? | THE "NEW" PROSTATE CANCER INFOLINK When should therapeutic intervention take place for men on active surveillance? | THE "NEW" PROSTATE CANCER INFOLINK](https://talkaboutprostatecancer.files.wordpress.com/2015/02/tnpcil2.png)
When should therapeutic intervention take place for men on active surveillance? | THE "NEW" PROSTATE CANCER INFOLINK
![Full article: Is prostate volume better than PSA density and free/total PSA ratio in predicting prostate cancer in patients with PSA 2.5–10 ng/mL and 10.1–30 ng/mL? Full article: Is prostate volume better than PSA density and free/total PSA ratio in predicting prostate cancer in patients with PSA 2.5–10 ng/mL and 10.1–30 ng/mL?](https://www.tandfonline.com/cms/asset/4b7cc902-9718-493a-b474-60050086132a/itam_a_1578741_f0001_c.jpg)